Clinical trial
The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat…
NCT00268840 · ARCAGY/ GINECO GROUP, Other · Completed
Key facts
| NCT number | NCT00268840 |
|---|---|
| Title | The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer |
| Official title | National Trial Phase II to Study the Combination of Gemcitabine and Docetaxel in Patients With Locally Advanced or Metastatic Pancreatic or Biliary Adenocarcinoma That Cannot be Removed by Surgery |
| Lead sponsor | ARCAGY/ GINECO GROUP, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Neoplasms, Biliary Tract Neoplasms |
| Intervention type | Drug |
| Interventions | Docetaxel, Gemcitabine |
| Enrollment | 45 |
| Start date | Aug 1, 2001 |
| Primary completion | Feb 1, 2006 |
| Completion | Feb 1, 2006 |
| First posted | Dec 23, 2005 |
| Last update posted | Jun 30, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: